赛诺医疗
(688108)
| 流通市值：40.56亿 | | | 总市值：40.56亿 |
| 流通股本：4.13亿 | | | 总股本：4.13亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 224,939,661.92 | 232,967,228.24 | 199,510,249.15 | 188,640,045.22 |
| 应收票据及应收账款 | 9,972,309.76 | 23,309,703.48 | 10,469,612.84 | 8,936,220.19 |
| 应收账款 | 9,972,309.76 | 23,309,703.48 | 10,469,612.84 | 8,936,220.19 |
| 预付款项 | 999,567.74 | 1,507,982.12 | 730,087.89 | 636,241.93 |
| 其他应收款合计 | 11,161,438.97 | 11,629,311.56 | 19,153,118.61 | 18,806,749.42 |
| 存货 | 120,649,871.7 | 123,823,611.18 | 122,027,231.36 | 118,220,173.59 |
| 其他流动资产 | 4,905,456.03 | 9,567,223.11 | 9,100,336.17 | 8,936,610.19 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 372,628,306.12 | 402,805,059.69 | 369,529,368.25 | 344,176,040.54 |
| 非流动资产: | | | | |
| 长期股权投资 | - | - | - | 14,003,447.72 |
| 固定资产 | 113,681,062.18 | 119,402,670.77 | 125,806,911.35 | 129,714,506.36 |
| 在建工程 | 1,832,324.37 | 1,177,407.48 | 1,403,712.59 | 1,551,302.45 |
| 使用权资产 | 28,716,614.03 | 31,735,417.85 | 32,539,770.46 | 34,679,432.57 |
| 无形资产 | 197,841,007.89 | 207,287,414.71 | 216,496,623.55 | 53,403,216.68 |
| 开发支出 | 377,364,683.16 | 355,785,360.55 | 336,375,045.94 | 331,823,588.24 |
| 商誉 | 59,451,752.77 | 59,451,752.77 | 59,451,752.77 | - |
| 长期待摊费用 | 26,810,420.09 | 32,686,916.87 | 38,756,723.06 | 44,090,123.85 |
| 递延所得税资产 | 101,626,364.9 | 106,165,024.1 | 108,256,284.95 | 105,325,720.41 |
| 其他非流动资产 | 120,000 | 272,000 | 6,720 | 127,054,001.16 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 907,444,229.39 | 913,963,965.1 | 919,093,544.67 | 841,645,339.44 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,280,072,535.51 | 1,316,769,024.79 | 1,288,622,912.92 | 1,185,821,379.98 |
| 流动负债: | | | | |
| 短期借款 | 48,542,583.3 | 63,055,736.1 | 53,550,094.44 | 53,554,648.62 |
| 应付票据及应付账款 | 21,015,189.5 | 23,217,668.84 | 24,521,729.12 | 28,170,465.48 |
| 应付账款 | 21,015,189.5 | 23,217,668.84 | 24,521,729.12 | 28,170,465.48 |
| 合同负债 | 1,095,720 | 423,714.55 | 938,380.34 | 1,116,218.54 |
| 应付职工薪酬 | 24,801,208.64 | 21,909,789.07 | 13,398,644.23 | 27,420,624.66 |
| 应交税费 | 2,287,482.76 | 5,391,693.36 | 3,213,173.15 | 3,234,782.44 |
| 其他应付款合计 | 49,431,006.75 | 48,936,046.61 | 49,262,269.65 | 21,922,773.33 |
| 一年内到期的非流动负债 | 9,443,611.54 | 8,433,365.42 | 15,035,843.1 | 15,716,007.04 |
| 其他流动负债 | 123,869.03 | 54,560.78 | 123,127.36 | 136,975.46 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 156,740,671.52 | 171,422,574.73 | 160,043,261.39 | 151,272,495.57 |
| 非流动负债: | | | | |
| 长期借款 | 59,300,000 | 59,300,000 | 59,300,000 | 50,300,000 |
| 租赁负债 | 20,189,971.55 | 23,157,337.86 | 22,616,779.43 | 24,920,448.24 |
| 长期应付款 | 88,950,000 | 88,950,000 | 88,950,000 | 55,000,000 |
| 预计负债 | - | - | 1,426,869.44 | 1,460,828.8 |
| 递延收益 | 13,921,776.78 | 16,620,815.62 | 18,342,883.81 | 20,999,366.67 |
| 递延所得税负债 | 42,120,169.03 | 43,549,200.29 | 44,945,995.41 | 20,218,449.57 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 224,481,917.36 | 231,577,353.77 | 235,582,528.09 | 172,899,093.28 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 381,222,588.88 | 402,999,928.5 | 395,625,789.48 | 324,171,588.85 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 413,456,000 | 413,456,000 | 410,000,000 | 410,000,000 |
| 资本公积 | 651,319,162.05 | 650,571,216.17 | 609,335,344.79 | 608,922,077.84 |
| 其他综合收益 | 414,936.96 | 823,137.23 | 653,240.05 | 1,972,184.16 |
| 盈余公积 | 33,792,200.7 | 33,792,200.7 | 33,792,200.7 | 33,792,200.7 |
| 未分配利润 | -241,473,911.19 | -227,067,449.5 | -232,230,858.56 | -234,729,458.31 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 857,508,388.52 | 871,575,104.6 | 821,549,926.98 | 819,957,004.39 |
| 少数股东权益 | 41,341,558.11 | 42,193,991.69 | 71,447,196.46 | 41,692,786.74 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 898,849,946.63 | 913,769,096.29 | 892,997,123.44 | 861,649,791.13 |
| 负债和股东权益合计 | 1,280,072,535.51 | 1,316,769,024.79 | 1,288,622,912.92 | 1,185,821,379.98 |
| 公告日期 | 2024-10-30 | 2024-08-20 | 2024-04-27 | 2024-04-27 |
| 审计意见(境内) | | | | 标准无保留意见 |